Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Xenon (XENE)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Argenx Se (ARGX – Research Report) and Xenon (XENE – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Argenx Se (ARGX)
TD Cowen analyst Yaron Werber maintained a Buy rating on Argenx Se yesterday and set a price target of $1146.00. The company’s shares closed last Thursday at $771.53.
According to TipRanks.com, Werber is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Argenx Se with a $1054.67 average price target, implying a 31.6% upside from current levels. In a report issued on February 19, Jefferies also maintained a Buy rating on the stock with a $1008.00 price target.
See the top stocks recommended by analysts >>
Xenon (XENE)
In a report released today, Myles Minter from William Blair reiterated a Buy rating on Xenon. The company’s shares closed last Thursday at $44.92, close to its 52-week high of $46.00.
According to TipRanks.com, Minter is a 5-star analyst with an average return of
Currently, the analyst consensus on Xenon is a Strong Buy with an average price target of $55.63, representing a 24.8% upside. In a report issued on February 23, Wolfe Research also initiated coverage with a Buy rating on the stock with a $60.00 price target.
